Company page

Atricure, Inc.

Atricure, Inc. is a public company listed under the ticker ATRC, operating in the American market. The company has a market capitalization of approximately $1.77 billion. Atricure focuses on developing innovative medical devices for the treatment of atrial fibrillation and other cardiac conditions.

ATRC:NASDAQUpdated August 21, 2026
Atricure, Inc. logo
Ticker
ATRC:NASDAQ
Asset type
Stock
Market cap
$2.49B
Sector
Health Technology
Industry
Medical Specialties
Exchange
NASDAQ
Currency
USD